Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing the power of human genetics to ...
Daily Maverick on MSN24m
Why the WHO has recommended switching to a healthier salt alternative
The World Health Organisation (WHO) has recently released new guidelines recommending people switch the regular salt they use at home for substitutes containing less sodium. But what exactly are these ...
New Hampshire man is 2nd person known to be living with a pig kidney
His effort paid off: Tim Andrews, 66, is only the second person known to be living with a pig kidney. Andrews is free from dialysis, Massachusetts General Hospital announced Friday, and recovering so ...